Resmed (RSMDF) Inventory Average (2010 - 2026)

Resmed has reported Inventory Average for 17 years, with the latest figure at $917.0 million in Q1 2026.

• For the quarter ending Q1 2026, Inventory Average rose 5.11% year-over-year to $917.0 million; the trailing twelve-month figure through Mar 2026 stood at $917.0 million (up 5.11% YoY), and the FY2025 full-year result was $875.0 million, down 3.86% from the prior year.
• Inventory Average for Q1 2026 stood at $917.0 million, down from $933.9 million in the prior quarter.
• The five-year high for Inventory Average was $1.0 billion in Q2 2023, with the low at $628.5 million in Q1 2022.
• Historically, Inventory Average has averaged $883.8 million across 5 years, with a median of $900.0 million in 2024.
• Annual changes were most pronounced in 2022 — Inventory Average soared 68.71% — and 2024, when it retreated 17.8%.
• Resmed's Inventory Average stood at $926.9 million in 2022, then advanced by 2.03% to $945.7 million in 2023, then decreased by 4.83% to $900.0 million in 2024, then climbed by 3.76% to $933.9 million in 2025, then decreased by 1.82% to $917.0 million in 2026.
• The last three Inventory Average figures came in at $917.0 million (Q1 2026), $933.9 million (Q4 2025), and $936.8 million (Q3 2025), per Business Quant data.